z-logo
open-access-imgOpen Access
Gliclazide monotherapy increases risks of all-cause mortality and has similar risk of acute myocardial infarction and stroke with glimepiride monotherapy in Korean type 2 diabetes mellitus
Author(s) -
Eunhee Cho,
Kyungdo Han,
Tae Hyuk Kim,
Dong Hoon Lee
Publication year - 2020
Publication title -
medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.59
H-Index - 148
eISSN - 1536-5964
pISSN - 0025-7974
DOI - 10.1097/md.0000000000021236
Subject(s) - medicine , glimepiride , gliclazide , stroke (engine) , metformin , hazard ratio , diabetes mellitus , myocardial infarction , type 2 diabetes , population , incidence (geometry) , insulin , endocrinology , confidence interval , mechanical engineering , physics , environmental health , optics , engineering

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here